Whole-Genome Sequencing of Salivary Gland Adenoid Cystic Carcinoma

Adenoid cystic carcinomas (ACC) of the salivary glands are challenging to understand, treat, and cure. To better understand the genetic alterations underlying the pathogenesis of these tumors, we performed comprehensive genome analyses of 25 fresh-frozen tumors, including whole-genome sequencing and expression and pathway analyses. In addition to the well-described MYB–NFIB fusion that was found in 11 tumors (44%), we observed five different rearrangements involving the NFIB transcription factor gene in seven tumors (28%). Taken together, NFIB translocations occurred in 15 of 25 samples (60%, 95% CI, 41%–77%). In addition, mRNA expression analysis of 17 tumors revealed overexpression of NFIB in ACC tumors compared with normal tissues (P = 0.002). There was no difference in NFIB mRNA expression in tumors with NFIB fusions compared with those without. We also report somatic mutations of genes involved in the axonal guidance and Rho family signaling pathways. Finally, we confirm previously described alterations in genes related to chromatin regulation and Notch signaling. Our findings suggest a separate role for NFIB in ACC oncogenesis and highlight important signaling pathways for future functional characterization and potential therapeutic targeting. Cancer Prev Res; 9(4); 265–74. ©2016 AACR.

[1]  Huining Kang,et al.  Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma. , 2016, Cancer discovery.

[2]  P. A. Futreal,et al.  Novel MYBL1 Gene Rearrangements with Recurrent MYBL1–NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations , 2015, Clinical Cancer Research.

[3]  B. Carneiro,et al.  Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling , 2015, Oncotarget.

[4]  Yi Zheng,et al.  Approaches of targeting Rho GTPases in cancer drug discovery , 2015, Expert opinion on drug discovery.

[5]  R. Karchin,et al.  Cleaved NOTCH1 Expression Pattern in Head and Neck Squamous Cell Carcinoma Is Associated with NOTCH1 Mutation, HPV Status, and High-Risk Features , 2015, Cancer Prevention Research.

[6]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of head and neck squamous cell carcinomas , 2015, Nature.

[7]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[8]  Min Zhang,et al.  A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets , 2014, Oncotarget.

[9]  R. Carrau,et al.  Clinicopathologic predictors of recurrence and overall survival in adenoid cystic carcinoma of the head and neck: A single institutional experience at a tertiary care center , 2014, Head & neck.

[10]  L. Wood,et al.  Somatic mutations of SUZ12 in malignant peripheral nerve sheath tumors , 2014, Nature Genetics.

[11]  A. Bass,et al.  Cellular senescence checkpoint function determines differential Notch1-dependent oncogenic and tumor suppressor activities , 2014, Oncogene.

[12]  Jane Y. Wu,et al.  Axon guidance factor SLIT2 inhibits neural invasion and metastasis in pancreatic cancer. , 2014, Cancer research.

[13]  Charity W. Law,et al.  voom: precision weights unlock linear model analysis tools for RNA-seq read counts , 2014, Genome Biology.

[14]  P. Stephens,et al.  Comprehensive Genomic Profiling of Relapsed and Metastatic Adenoid Cystic Carcinomas by Next-generation Sequencing Reveals Potential New Routes to Targeted Therapies , 2014, The American journal of surgical pathology.

[15]  K. Kinzler,et al.  Mutational Signature of Aristolochic Acid Exposure as Revealed by Whole-Exome Sequencing , 2013, Science Translational Medicine.

[16]  M. Stratton,et al.  Whole exome sequencing of adenoid cystic carcinoma. , 2013, The Journal of clinical investigation.

[17]  Benjamin J. Raphael,et al.  The Mutational Landscape of Adenoid Cystic Carcinoma , 2013, Nature Genetics.

[18]  Liliana Goumnerova,et al.  Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1 , 2013, Proceedings of the National Academy of Sciences.

[19]  Ning Leng,et al.  EBSeq: an empirical Bayes hierarchical model for inference in RNA-seq experiments , 2013, Bioinform..

[20]  Giovanni Parmigiani,et al.  Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma , 2012, Nature Genetics.

[21]  R. Ferris,et al.  Molecular biology of adenoid cystic carcinoma , 2012, Head & neck.

[22]  P. A. Futreal,et al.  Clinically significant copy number alterations and complex rearrangements of MYB and NFIB in head and neck adenoid cystic carcinoma , 2012, Genes, chromosomes & cancer.

[23]  J. Aster,et al.  Targeting the Notch pathway: twists and turns on the road to rational therapeutics. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Wonshik Han,et al.  NFIB is a potential target for estrogen receptor‐negative breast cancers , 2011, Molecular oncology.

[25]  G. Hostetter,et al.  Perineural invasion and associated pain in pancreatic cancer , 2011, Nature Reviews Cancer.

[26]  C. Moskaluk,et al.  Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms , 2011, Modern Pathology.

[27]  R. Gibbs,et al.  Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1 , 2011, Science.

[28]  S. Salzberg,et al.  TopHat-Fusion: an algorithm for discovery of novel fusion transcripts , 2011, Genome Biology.

[29]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[30]  Levi Garraway,et al.  Nuclear factor I/B is an oncogene in small cell lung cancer. , 2011, Genes & development.

[31]  A. Capobianco,et al.  Notch signalling in solid tumours: a little bit of everything but not all the time , 2011, Nature Reviews Cancer.

[32]  R. West,et al.  MYB Expression and Translocation in Adenoid Cystic Carcinomas and Other Salivary Gland Tumors With Clinicopathologic Correlation , 2011, The American journal of surgical pathology.

[33]  Paola Chiarugi,et al.  Rac and Rho GTPases in cancer cell motility control , 2010, Cell Communication and Signaling.

[34]  R. Weber,et al.  Comprehensive Analysis of the MYB-NFIB Gene Fusion in Salivary Adenoid Cystic Carcinoma: Incidence, Variability, and Clinicopathologic Significance , 2010, Clinical Cancer Research.

[35]  M. Wjst,et al.  Copy number variation and association over T-cell receptor genes—influence of DNA source , 2010, Immunogenetics.

[36]  H. Horlings,et al.  Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck , 2009, Proceedings of the National Academy of Sciences.

[37]  Hiromi Nakamura,et al.  ASK1 and ASK2 differentially regulate the counteracting roles of apoptosis and inflammation in tumorigenesis , 2009, The EMBO journal.

[38]  A. Italiano,et al.  NFIB rearrangement in superficial, retroperitoneal, and colonic lipomas with aberrations involving chromosome band 9p22 , 2008, Genes, chromosomes & cancer.

[39]  E. Sahai,et al.  Rac Activation and Inactivation Control Plasticity of Tumor Cell Movement , 2008, Cell.

[40]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[41]  Robert G. Ramsay,et al.  MYB function in normal and cancer cells , 2008, Nature Reviews Cancer.

[42]  A. Ridley,et al.  Rho GTPases in cancer cell biology , 2008, FEBS letters.

[43]  J. Lacal,et al.  Rho GTPase expression in tumourigenesis: Evidence for a significant link , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.

[44]  Andrew I Su,et al.  Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. , 2002, The American journal of pathology.

[45]  J. Camonis,et al.  Mutation status of genes encoding RhoA, Rac1, and Cdc42 GTPases in a panel of invasive human colorectal and breast tumors , 2001, Journal of Cancer Research and Clinical Oncology.

[46]  H. Goepfert,et al.  Adenoid cystic carcinoma of the head and neck: Predictors of morbidity and mortality , 1999 .

[47]  E. Schoenmakers,et al.  Identification of NFIB as recurrent translocation partner gene of HMGIC in pleomorphic adenomas , 1998, Oncogene.

[48]  M. Jaggi,et al.  Slit/Robo pathway: a promising therapeutic target for cancer. , 2015, Drug discovery today.